Skip to main content

Table 1 Baseline patient, lesion and procedural characteristics

From: Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

  Baseline characteristics, No. (%)
Normoglycemia
n = 2353
Prediabetes
n = 489
Diabetes
n = 1488
P-value
Age, mean (SD), years 62.9 (10.8) 64.6 (10.8) 65.7 (10.6) < 0.001
Female 568 (24.1) 142 (29.0) 439 (29.5) < 0.001
Body mass index, mean (SD), kg/m2 26.9 (3.8) 27.9 (4.3) 29.1 (4.7) < 0.001
Hypertension 933 (39.7) 236/488 (48.4) 948/1484 (63.9) < 0.001
Hypercholesterolemia 909/2351 (38.7) 204/488 (41.8) 746/1479 (50.4) < 0.001
Current smoker 764/2299 (33.2) 140/467 (30.0) 376/1440 (26.1) < 0.001
Renal insufficiencya 55 (2.3) 21 (4.3) 114 (7.7) < 0.001
Previous stroke 137 (5.8) 35 (7.2) 137 (9.2) < 0.001
Previous myocardial infarction 350 (14.9) 91 (18.6) 320 (21.5) < 0.001
Previous PCI 359 (15.3) 100 (20.4) 368 (24.7) < 0.001
Previous CABG 140 (5.9) 40 (8.2) 156 (10.5) < 0.001
Clinical presentation 0.001
 STEMI 763 (32.4) 146 (29.9) 379 (25.5)  
 Non-STEMI 521 (22.1) 98 (20.0) 345 (23.2)  
 Unstable angina 389 (16.5) 94 (19.2) 278 (18.7)  
 Stable angina 680 (28.9) 151 (30.9) 486 (32.7)  
Lesion and procedural characteristics
 At least 1 severely calcified lesion 450 (19.1) 108 (22.1) 344 (23.1) 0.009
 At least 1 bifurcation treated 828 (35.2) 183 (37.4) 551 (37.0) 0.41
 Graft treated 32 (1.4) 12 (2.5) 37 (2.5) 0.026
 Small vessel treated (< 2.75mm) 1256 (53.4) 282 (57.7) 910 (61.2) < 0.001
 Multivessel treatment 398 (16.9) 100 (20.4) 275 (18.5) 0.13
 Total stent length/patient, median (IQR) 32 (20–52) 31 (20–53) 30 (18–48) 0.86
 Direct stenting 265 (15.6) 53 (14.1) 147 (16.1) 0.67
 Postdilation 1913 (81.3) 399 (81.6) 1,121(75.3) < 0.001
 Number of diseased vessels > 50 % angiographic stenosis     < 0.001
  One vessel disease 1380 (58.6) 274 (56.0) 757 (50.9)  
  Two vessel disease 737 (31.3) 158 (32.3) 487 (32.7)  
  Three vessel disease 236 (10.0) 57 (11.7) 244 (16.4)  
  1. Values are n/N (%), mean (SD), or median (IQR)
  2. CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; STEMI, ST-segment-elevation myocardial infarction; NSTEMI, non-ST-segment-elevation myocardial infarction
  3. aDefined as creatinine level ≥ 130 µmol/l, an estimated glomerular filtration rate of less than 30 ml per minute per 1.73 m2 of body-surface area, or the need for dialysis